Technical Analysis for ATHE - Alterity Therapeutics Limited

Grade Last Price % Change Price Change
grade D 1.12 -5.87% -0.07
ATHE closed down 5.87 percent on Wednesday, August 21, 2019, on 46 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical ATHE trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Weak + Overbought Other 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Crossed Above 50 DMA Bullish -5.87%
Pocket Pivot Bullish Swing Setup -5.87%
Stochastic Reached Overbought Strength -5.87%
Above Upper BB Strength -5.87%
Overbought Stochastic Strength -5.87%

Older signals for ATHE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Alterity Therapeutics Ltd formerly known as Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Neuroscience Parkinson's Disease Anatomy Treatment Of Parkinson's Disease Movement Disorders Alzheimer's Anatomical Pathology Brain Cancer Neurology Parkinson's
Is ATHE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.72
52 Week Low 0.91
Average Volume 36,387
200-Day Moving Average 1.537
50-Day Moving Average 1.175
20-Day Moving Average 1.038
10-Day Moving Average 1.0635
Average True Range 0.0911
ADX 30.25
+DI 29.5115
-DI 9.2116
Chandelier Exit (Long, 3 ATRs ) 1.2167
Chandelier Exit (Short, 3 ATRs ) 1.1833
Upper Bollinger Band 1.1914
Lower Bollinger Band 0.8846
Percent B (%b) 0.77
BandWidth 29.55684
MACD Line -0.0114
MACD Signal Line -0.0423
MACD Histogram 0.0308
Fundamentals Value
Market Cap 1.66 Million
Num Shares 1.48 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -1.70
Price-to-Sales 1.84
Price-to-Book 1.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.21
Resistance 3 (R3) 1.22 1.20 1.20
Resistance 2 (R2) 1.20 1.18 1.20 1.19
Resistance 1 (R1) 1.16 1.16 1.15 1.15 1.18
Pivot Point 1.14 1.14 1.14 1.14 1.14
Support 1 (S1) 1.10 1.12 1.09 1.09 1.06
Support 2 (S2) 1.08 1.10 1.08 1.05
Support 3 (S3) 1.04 1.08 1.05
Support 4 (S4) 1.03